Grow Therapy Raises $150 Million in Series D Funding

Mental health platform Grow Therapy has raised $150 million in Series D financing, announced in a press release. The round was led by existing investors TCV and Goldman Sachs Alternatives, with new participation from BCI and Menlo Ventures, alongside continued backing from Sequoia, SignalFire, and Transformation Capital.

Grow Therapy reported that it facilitated seven million therapy and medication management visits in 2025, bringing its total to 10 million since launch. The company’s AI-assisted clinical note tools have reduced provider documentation time by approximately 70%, while maintaining accuracy. Its mobile app offers clinically guided AI tools for patient self-reflection and progress tracking between sessions.

Since its Series C in 2024, Grow Therapy has expanded insurance coverage from 75 to more than 125 health insurers, including Medicare and Medicaid, reaching 220 million people nationwide. The platform has also formed new partnerships with major insurers such as Guidewell and Lucet to improve care coordination and outcomes.

The company plans to extend its services further into employer-sponsored mental health programs and health systems, including Circle Medical. These initiatives aim to improve continuity of care and streamline access to therapy and psychiatric services across digital and in-person settings.